Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-09-30
1984-10-30
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31225
Patent
active
044799675
ABSTRACT:
The invention relates to a method of lowering intraocular pressure by a topical application of 2-tert-butylamino-1-(3,5-diisobutyryloxyphenyl)-ethanol or an acid addition salt thereof onto the eye of a mammalian species including man, especially as a conservative and/or curative medical treatment of ocular hypertension and pathological states associated therewith, in the first line glaucoma. The invention also relates to ophthalmic preparations for the topical application comprising an effective amount of the above-identified compounds in combination with a pharmaceutically acceptable carrier, and a method for producing themselves by non-chemical means.
REFERENCES:
patent: 3341594 (1967-09-01), Thoma et al.
patent: 3775479 (1973-11-01), Bruderer et al.
patent: 3839584 (1974-10-01), Hussain et al.
patent: 3937838 (1976-02-01), Wetterlin et al.
patent: 3954871 (1976-05-01), Buu-Hoi et al.
patent: 4011258 (1977-03-01), Wetterlin et al.
patent: 4145441 (1979-03-01), Bodor
patent: 4275074 (1981-06-01), Langham
patent: 4415564 (1983-11-01), Gamba et al.
Hussain et al., Novel Epinepherine Prodrug; J. Pharmaceutical Sciences 65, 1510, (1976).
Wettrell et al., Effect of Beta-Adrenergic Agonists and Antagonists; Exp. Eye Res. 24, 613-619, (1977).
Olsson et al., Pharmacological Properties of KWD 2058; Acta Pharmacol. et Toxicol 35, 76-90, (1974).
Rowland et al., Effects of Adrenergic Drugs; Graefes Archiv Ophthalmologie, 212, 65-75, (1979).
Poulsen et al., Comparison of Ibuterol and Terbutaline in Inhalation Form; Scand J. Respir. Dis. 57, 97-98, (1976).
Johnson et al., Brit. Med. J., Apr. 16, 1977, p. 1006, Ibuterol vs. Terbutaline Inhalation.
Helstr/o/ m et al., Ibuterol and Terbutaline in Asthmatics; Scand. J. Resp. Dis. 58, 247-251, (1977).
Poulsen et al., Ibuterol Hydrodchloride and Terbutaline in Asthma; Brit. Med. J., Apr. 3, 1976, p. 835.
Alm et al., Effect of Prenalterol, Acta Ophthlmologica 59, 882, (1981).
Lasson et al., Comparison of Intravenous Ibuterol (KWD 2058) and Terbutaline, Europ. J. Clin. Pharmcol. 11, 429-433, (1977).
Rowland et al., Adrenergic Drugs and Intraoculr Pressure, Exp. Eye Res. 30, 93-104, (1980).
Potter et al., Adrenergic Drugs and Intraocular Pressure, Exp. Eye Res. 27, 615-625, (1978).
Chemical Abstracts, vol. 84, 159651M, (1976), H. Persson et al., Sympathomimetic Bronchodilating Agents.
Chemical Abstracts, vol. 84, 72204x, (1976), P. Andersson, Bronchospasmolytic and Cardiovascular Effects of Ibuterol and Terbutalinc.
Ciba-Geigy Corporation
Gruenfeld Norbert
Robinson Douglas W.
LandOfFree
Method of lowering intraocular pressure with ibuterol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of lowering intraocular pressure with ibuterol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of lowering intraocular pressure with ibuterol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1102015